Erratum: Kundumani-Sridharan V, Niu J, Wang D, et al. 15(S)-hydroxyeicosatetraenoic acid–induced angiogenesis requires Src-mediated Egr-1–dependent rapid induction of FGF-2 expression. Blood. 2010;115(10):2105-2116. (Blood (2010) 115(10) (2105–2116), (S0006497120566810), (10.1182/blood-2009-09-241802));15(S)-hydroxyeicosatetraenoic acid-induced angiogenesis requires Src-mediated Egr-1-dependent rapid induction of FGF-2 expression

Blood

Volumn 115, Issue 10, 2010, Pages 2105-2116

  Kundumani Sridharan, Venkatesh ^a   Niu, Jixiao ^a   Wang, Dong ^a   Van Quyen, Dong ^a   Zhang, Qiuhua ^a   Singh, Nikhlesh K ^a   Subramani, Jaganathan ^a   Karri, Saradasri ^a   Rao, Gadiparthi N ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; EARLY GROWTH RESPONSE FACTOR 1; FIBROBLAST GROWTH FACTOR 2; HYDROXYICOSATETRAENOIC ACID; NEUTRALIZING ANTIBODY; PROTEIN TYROSINE KINASE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; ATHEROSCLEROSIS; BINDING SITE; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; GENE MUTATION; HUMAN; HUMAN CELL; MOLECULAR CLONING; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RESTENOSIS; TRANSCRIPTION INITIATION SITE; VASCULAR ENDOTHELIUM; WILD TYPE;

EID: 77950398950     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood.2021010742     Document Type: Erratum

References (48)

1. Sigal E, Craik CS, Highland E, et al. Molecular cloning and primary structure of human 15-lipoxygenase. Biochem Biophys Res Commun. 1988; 157(2):457-464.
2. Brash AR, Boeglin WE, Chang MS. Discovery of a second 15S-lipoxygenase in humans. Proc Natl Acad Sci U S A. 1997;94(12):6148-6152.
3. Bryant RW, Bailey JM, Schewe T, Rapoport SM. Positional specificity of a reticulocyte lipoxygenase. Conversion of arachidonic acid to 15-Shydroperoxy-eicosatetraenoic acid. J Biol Chem. 1982;257(11):6050-6055.
4. Chang MS, Schneider C, Roberts RL, et al. Detection and subcellular localization of two 15Slipoxygenases in human cornea. Invest Ophthalmol Vis Sci. 2005;46(3):849-856. (Pubitemid 41321020)
5. Kelavkar UP, Nixon JB, Cohen C, Dillehay D, Eling TE, Badr KF. Overexpression of 15-lipoxygenase-1 in PC-3 human prostate cancer cells increases tumorigenesis. Carcinogenesis. 2001; 22(11):1765-1773. (Pubitemid 33064840)
6. Shappell SB, Olson SJ, Hannah SE, et al. Elevated expression of 12/15-lipoxygenase and cyclooxygenase-2 in a transgenic mouse model of prostate carcinoma. Cancer Res. 2003;63(9): 2256-2267.
7. Tang S, Bhatia B, Maldonado CJ, et al. Evidence that arachidonate 15-lipoxygenase 2 is a negative cell cycle regulator in normal prostate epithelial cells. J Biol Chem. 2002;277(18):16189-16201.
8. Bhatia B, Maldonado CJ, Tang S, et al. Subcellular localization and tumor-suppressive functions of 15-lipoxygenase 2 (15-LOX2) and its splice variants. J Biol Chem. 2003;278(27):25091-25100. (Pubitemid 37548673)
9. Liu B, Maher RJ, De Jonckheere JP, et al. 12(S)-HETE increases the motility of prostate tumor cells through selective activation of PKC alpha. Adv Exp Med Biol. 1997;400B:707-718. (Pubitemid 127734688)
10. Tang DG, Renaud C, Stojakovic S, Diglio CA, Porter A, Honn KV. 12(S)-HETE is a mitogenic factor for microvascular endothelial cells: its potential role in angiogenesis. Biochem Biophys Res Commun. 1995;211(2):462-468.
11. Shappell SB, Gupta RA, Manning S, et al. 15SHydroxyeicosatetraenoic acid activates peroxisome proliferator-activated receptor gamma and inhibits proliferation in PC3 prostate carcinoma cells. Cancer Res. 2001;61(2):497-503.
12. Shureiqi I, Chen D, Lotan R, et al. 15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory druginduced apoptosis independently of cyclooxygenase-2 in colon cancer cells. Cancer Res. 2000; 60(24):6846-6850. (Pubitemid 32059150)
13. Shureiqi I, Jiang W, Zuo X, et al. The 15-lipoxygenase-1 product 13-S-hydroxyoctadecadienoic acid down-regulates PPAR-delta to induce apoptosis in colorectal cancer cells. Proc Natl Acad Sci U S A. 2003;100(17):9968-9973. (Pubitemid 37087052)
14. Heydeck D, Upston JM, Viita H, Yla-Herttuala S, Stocker R. Oxidation of LDL by rabbit and human 15-lipoxygenase: prevalence of nonenzymatic reactions. J Lipid Res. 2001;42(7):1082-1088. (Pubitemid 32645789)
15. Zhao L, Funk CD. Lipoxygenase pathways in atherogenesis. Trends Cardiovasc Med. 2004; 14(5):191-195.
16. Henriksson P, Hamberg M, Diczfalusy U. Formation of 15-HETE as a major hydroxyeicosatetraenoic acid in the atherosclerotic vessel wall. Biochim Biophys Acta. 1985;834(2):272-274.
17. Cyrus T, Witztum JL, Rader DJ, et al. Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice. J Clin Invest. 1999;103(11):1597-1604.
18. Gu JL, Pei H, Thomas L, et al. Ribozymemediated inhibition of rat leukocyte-type 12-lipoxygenase prevents intimal hyperplasia in balloon-injured rat carotid arteries. Circulation. 2001;103(10):1446-1452. (Pubitemid 32220639)
19. Harats D, Shaish A, George J, et al. Overexpression of 15-lipoxygenase in vascular endothelium accelerates early atherosclerosis in LDL receptordeficient mice. Arterioscler Thromb Vasc Biol. 2000;20(9):2100-2105.
20. Augustin AJ, Grus FH, Koch F, Spitznas M. Detection of eicosanoids in epiretinal membranes of patients suffering from proliferative vitreoretinal diseases. Br J Ophthalmol. 1997;81(1):58-60.
21. Zhu D, Medhora M, Campbell WB, Spitzbarth N, Baker JE, Jacobs ER. Chronic hypoxia activates lung 15-lipoxygenase, which catalyzes production of 15-HETE and enhances constriction in neonatal rabbit pulmonary arteries. Circ Res. 2003; 92(9):992-1000. (Pubitemid 36588498)
22. Setty BN, Ganley C, Stuart MJ. Effect of changes in oxygen tension on vascular and platelet hydroxyacid metabolites. II. Hypoxia increases 15-hydroxyeicosatetraenoic acid, a proangiogenic metabolite. Pediatrics. 1985;75(5):911-915.
23. Graeber JE, Glaser BM, Setty BN, Jerdan JA, Walenga RW, Stuart MJ. 15-Hydroxyeicosatetraenoic acid stimulates migration of human retinal microvessel endothelium in vitro and neovascularization in vivo. Prostaglandins. 1990;39(6):665-673.
24. Bajpai AK, Blaskova E, Pakala SB, et al. 15(S)-HETE production in human retinal microvascular endothelial cells by hypoxia: novel role for MEK1 in 15(S)-HETE-induced angiogenesis. Invest Ophthalmol Vis Sci. 2007;48(11):4930- 4938.
25. Zhang B, Cao H, Rao GN. 15(S)-hydroxyeicosatetraenoic acid induces angiogenesis via activation of PI3K-Akt-mTOR-S6K1 signaling. Cancer Res. 2005;65(16):7283-7291. (Pubitemid 41161260)
26. Srivastava K, Kundumani-Sridharan V, Zhang B, Bajpai AK, Rao GN. 15(S)-hydroxyeicosatetraenoic acid-induced angiogenesis requires STAT3-dependent expression of VEGF. Cancer Res. 2007;67(9):4328-4336. (Pubitemid 46815081)
27. Abdel-Malak NA, Mofarrahi M, Mayaki D, Khachigian LM, Hussain SN. Early growth response-1 regulates angiopoietin-1-induced endothelial cell proliferation, migration, and differentiation. Arterioscler Thromb Vasc Biol. 2009; 29(2):209-216.
28. Grotegut S, von Schweinitz D, Christofori G, Lehembre F. Hepatocyte growth factor induces cell scattering through MAPK/Egr-1-mediated upregulation of Snail. EMBO J. 2006;25(15): 3534-3545. (Pubitemid 44264864)
29. Fahmy RG, Dass CR, Sun LQ, Chesterman CN, Khachigian LM. Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth. Nat Med. 2003;9(8):1026-1032. (Pubitemid 37021782)
30. Du B, Fu C, Kent KC, et al. Elevated Egr-1 in human atherosclerotic cells transcriptionally represses the transforming growth factor-beta type II receptor. J Biol Chem. 2000;275(50):39039-39047. (Pubitemid 32058917)
31. Lowe HC, Fahmy RG, Kavurma MM, Baker A, Chesterman CN, Khachigian LM. Catalytic oligodeoxynucleotides define a key regulatory role for early growth response factor-1 in the porcine model of coronary in-stent restenosis. Circ Res. 2001;89(8):670-677. (Pubitemid 34627066)
32. Jin Y, Sheikh F, Detillieux KA, Cattini PA. Role for early growth response-1 protein in alpha(1)-adrenergic stimulation of fibroblast growth factor-2 promoter activity in cardiac myocytes. Mol Pharmacol. 2000;57(5):984-990. (Pubitemid 30253383)
33. Zhao HY, Ooyama A, Yamamoto M, et al. Molecular basis for the induction of an angiogenesis inhibitor, thrombospondin-1, by 5-fluorouracil. Cancer Res. 2008;68(17):7035-7041.
34. Shah F, Balan P, Weinberg M, et al. Contrast-enhanced ultrasound imaging of atherosclerotic carotid plaque neovascularization: a new surrogate marker of atherosclerosis? Vasc Med. 2007; 12(4):291-297.
35. Khurana R, Zhuang Z, Bhardwaj S, et al. Angiogenesis-dependent and independent phases of intimal hyperplasia. Circulation. 2004;110(16): 2436-2443. (Pubitemid 39407351)
36. Madden SL, Cook DM, Morris JF, Gashler A, Sukhatme VP, Rauscher FJ 3rd. Transcriptional repression mediated by the WT1 Wilms tumor gene product. Science. 1991;253(5027):1550-1553.
37. Cheranov SY, Karpurapu M, Wang D, Zhang B, Venema RC, Rao GN. An essential role for SRC-activated STAT-3 in 14,15-EET-induced VEGF expression and angiogenesis. Blood. 2008; 111(12):5581-5591.
38. Cheranov SY, Wang D, Kundumani-Sridharan V, et al. The 15(S)-hydroxyeicosatetraenoic acid-induced angiogenesis requires Janus kinase 2-signal transducer and activator of transcription-5B-dependent expression of interleukin-8. Blood. 2009;113(23):6023-6033.
39. Tang DG, Renaud C, Stojakovic S, Diglio CA, Porter A, Honn KV. 12(S)-HETE is a mitogenic factor for microvascular endothelial cells: its potential role in angiogenesis. Biochem Biophys Res Commun. 1995;211(2):462-468.
40. Simon TC, Makheja AN, Bailey JM. Formation of 15-hydroxyeicosatetraenoic acid (15-HETE) as the predominant eicosanoid in aortas from Watanabe heritable hyperlipidemic and cholesterolfed rabbits. Atherosclerosis. 1989;75(1):31-38.
41. Chava KR, Karpurapu M, Wang D, et al. CREB-mediated IL-6 expression is required for 15(S)-hydroxyeicosatetraenoic acid-induced vascular smooth muscle cell migration. Arterioscler Thromb Vasc Biol. 2009;29(6):809-815.
42. Potula HSK, Wang D, Quyen DV, et al. Src-dependent STAT-3-mediated expression of monocyte chemoattractant protein-1 is required for 15(S)-hydroxyeicosatetraenoic acid-induced vascular smooth muscle cell migration. J Biol Chem. 2009;284(45):31142-31155.
43. Poole TJ, Finkelstein EB, Cox CM. The role of FGF and VEGF in angioblast induction and migration during vascular development. Dev Dyn. 2001;220(1):1-17.
44. Wang D, Mayo MW, Baldwin AS Jr. Basic fibroblast growth factor transcriptional autoregulation requires EGR-1. Oncogene. 1997;14(19):2291-2299. (Pubitemid 27260721)
45. Hughes SE, Crossman D, Hall PA. Expression of basic and acidic fibroblast growth factors and their receptor in normal and atherosclerotic human arteries. Cardiovasc Res. 1993;27(7):1214-1219.
46. Lindner V, Lappi DA, Baird A, Majack RA, Reidy MA. Role of basic fibroblast growth factor in vascular lesion formation. Circ Res. 1991;68(1):106-113.
47. Cornicelli JA, Trivedi BK. 15-Lipoxygenase and its inhibition: a novel therapeutic target for vascular disease. Curr Pharm Des. 1999;5(1):11-20. (Pubitemid 29068274)
48. Bocan TM, Rosebury WS, Mueller SB, et al. A specific 15-lipoxygenase inhibitor limits the progression and monocyte-macrophage enrichment of hypercholesterolemia-induced atherosclerosis in the rabbit. Atherosclerosis. 1998;136(2):203-216.